Therapeutic Targeting of Lipid Nanoparticles
US-2024131181-A1 · Apr 25, 2024 · US
US9402926B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9402926-B2 |
| Application number | US-201414255210-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 17, 2014 |
| Priority date | Jul 10, 2008 |
| Publication date | Aug 2, 2016 |
| Grant date | Aug 2, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Embodiments of the present disclosure provide for nanoprobes, methods of imaging, methods of imaging a target, methods of making nanoprobes, and the like.
Opening claim text (preview).
We claim the following: 1. A nanoprobe, comprising: a superparamagnetic iron oxide (SPIO) nanoparticle, wherein the SPIO nanoparticle has a silanization coating on the surface of the SPIO nanoparticle, wherein the silanization coating is about 5 to about 1000 nm thick, or more, does not include silicates or silica, and is made of cross-linked trimethoxyl silanes that are cross-linked with two or more different types of functional groups, wherein the functional groups are selected from the group consisting of: an amino group, a mercapto group, a carboxyl group, a phosphonate group, a polyethylene oxide group (PEG), a hydroxyl group, an alkyl group and a combination thereof. 2. The nanoprobe of claim 1 , further comprising at least ten fluorescent compounds attached to the silanization coating. 3. The nanoprobe of claim 1 , wherein the SPIO nanoparticle has a diameter of about 3 nm to 40 nm. 4. The nanoprobe of claim 1 , wherein silanization coating is amorphous and controllable to about 5 nm to 500 nm thick. 5. The nanoprobe of claim 1 , wherein the SPIO nanoparticle is a product of an oxidative decomposition of iron pentacarbonyl with a compound selected from the group consisting of: trimethylamine oxide, oleic acid, hexadecane, and a combination thereof. 6. The nanoprobe of claim 2 , wherein the fluorescent compounds are attached to the silanization coating through an interaction selected from the group consisting of: covalent bond, a non-covalent bond, an ionic bond, a chelation interaction, a hydrophobic interaction, a hydrophilic interaction, a charge-charge interaction, and a π-stacking interaction. 7. The nanoprobe of claim 1 , wherein the SPIO nanoparticles are precipitated with isopropanol prior to silanization. 8. The nanoprobe of claim 2 , wherein the fluorescent compounds are attached to the silanization coating via at least one of the types of functional group. 9. The nanoprobe of claim 1 , wherein the silanization coating includes biotin. 10. The nanoprobe of claim 9 , wherein a streptavidin-fluorescent compound is attached to the silanization coating via biotin. 11. The nanoprobe of claim 1 , wherein a targeting moiety is attached to the silanization coating, wherein the targeting moiety has an affinity for a target. 12. The nanoprobe of claim 2 , wherein the fluorescent compound is a fluorophore. 13. The nanoprobe of claim 1 , wherein the iron oxide nanoparticle comprises one or more particles composed of a phase selected from the group consisting of: a maghemite ((γ-Fe 2 O 3 ) phase, a magnetite (Fe 3 O 4 ) phase, and a combination of both phases. 14. The nanoprobe of claim 1 , wherein at least one type of fluorescent compound is attached to one type of functional group; and at least one second type of compound is attached to the other type of functional group, wherein the second type of compound is selected from: a second type of fluorescent compound, a targeting moiety, a drug, a therapeutic agent, a radiological agent, a chemological agent, a small molecule drug, and a biological agent. 15. The nanoprobe of claim 1 , wherein the silanization coating does not change the magnetic properties of the original SPIO nanoparticle. 16. The nanoprobe of claim 1 , wherein the silanization coating includes amino functional groups and mercapto functional groups. 17. The nanoprobe of claim 16 , wherein a portion of the amino functional groups are attached to fluorescent compounds, where each amino functional group of the portion is attached to a fluorescent compound; and a portion of the mercapto functional groups are attached to targeting moieties, wherein each mercapto functional group of the portion is attached to a targeting moiety. 18. A nanoprobe, comprising: a superparamagnetic iron oxide (SPIO) nanoparticle, wherein the SPIO nanoparticle has a silanization coating on the surface of the SPIO nanoparticle, wherein the silanization coating is about 5 nm to 1000 nm thick, does not include silicates or silica, and includes two or more different functional groups, wherein the functional groups are selected from the group consisting of: an amino group, a mercapto group, a carboxyl group, a phosphonate group, a polyethylene oxide group (PEG), a hydroxyl group, an alkyl group and a combination thereof, and at least ten fluorescent compounds attached to the functional groups of the silanization coating, wherein each fluorescent compound is attached to the silanization coating via a functional group, and wherein the silanization coating provides a protective effect for the fluorescent compound.
the nanoparticle having a (super)(para)magnetic core coated or functionalised with a peptide, e.g. protein, polyamino acid · CPC title
microparticles or nanoparticles, e.g. polymeric nanoparticles · CPC title
the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo · CPC title
characterised by the carrier molecule carrying the fluorescent agent · CPC title
Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.